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Abstract
Background: Hepatic pregnancy is a rare form of abdominal pregnancy, often documented only as case reports.
Case presentation: We report here the case of a 24-year-old African woman, gravida 4 para 3, presenting with right
upper quadrant pains and metrorrhagia after amenorrhea of 8 weeks 5 days. Elements in favor of the diagnosis of hepatic
pregnancy were her clinical presentation, the kinetics of β-human chorionic gonadotropin titers, and the presence of a
sub-hepatic mass on ultrasound. We successfully treated this patient with intramuscular methotrexate only.
Conclusions: The interest of this case resides in the rarity of this condition and the therapeutic approach used. Clinicians
should raise their index of suspicion for hepatic pregnancy when faced with females of reproductive age with such a
clinical presentation.
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Background
Abdominal pregnancies constitute 1.4 % of ectopic preg-
nancies. This rare form of ectopic pregnancy is associ-
ated with high mortality due to diagnostic challenges
and the massive intraperitoneal hemorrhage caused by
the removal of the placenta [1]. A hepatic location is ex-
tremely rare and described only as case reports. In these
circumstances, treatment options are not as well defined
as they are with tubal ectopic pregnancy. We present
this case of hepatic pregnancy diagnosed with non-
invasive explorations and medical treatment.
Case presentation
A 24-year-old African woman, gravida 4 para 3, pre-
sented with a 2-week history of right upper quadrant
pain and an 8 weeks and 5 days amenorrhea with spot-
ting. She first consulted in a secondary health facility
where her clinical evaluation revealed a hepatomegaly
on abdominopelvic ultrasound and positive urinary preg-
nancy test without intrauterine or tubal gestational sac.
These findings motivated the medical team to refer her
to our tertiary center.
This was her first episode of such pain. She had no
history of sexually transmitted diseases and no history of
contraception. She had never had an operation. Her
hepatitis B and C status were unknown. There was no
dizziness, asthenia, or jaundice.
Her vital signs were stable: blood pressure of 120/
60 mm Hg, pulse rate of 70 beats per minute, respiratory
rate of 16 cycles per minute, and temperature at 36.5 °C.
She weighed 59 kg. She was not pale. Her right upper
quadrant was tender on deep palpation but not after
deep breath. There was no guarding or rebound tender-
ness. Her uterus was of normal size and there were no
adnexal masses noted. Her rectovaginal pouch was free
and non-tender. We suspected acute cholecystitis or
acute viral hepatitis in pregnancy.
On another abdominopelvic ultrasound, a heteroge-
neous poorly vascularized mass was visible under the
right lobe of her liver, of size 42 × 38 mm. There was no
hemoperitoneum and her uterus was empty without ad-
nexal masses. On full blood count, there was mild
microcytic and hypochromic anemia at 10.2 g per dL,
with normal leukocyte and platelet counts. Her liver
transaminases and renal function were normal. Her
serum β-human chorionic gonadotropin (βhCG) titers
rose from 200 mUI/mL to 3000 mUI/mL in 48 hours.
No gestational sac was visible on concomitant pelvic
ultrasound.
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Our final diagnosis was hepatic pregnancy. We chose
to administer 1 mg/kg of methotrexate intramuscularly
since she was hemodynamically stable and the Fernan-
dez score [2] was in favor of medical treatment. Evolu-
tion was favorable and she was discharged at day 5. Two
weeks later, her serum βhCG titer was 15 mUI/mL. She
did not show up at 1-month appointment.
Discussion
Abdominal pregnancy is a rare form of ectopic preg-
nancy. It occurs in 9.2 per 1000 ectopic pregnancies [1].
Location in the liver is extremely rare. Using “hepatic
pregnancy”, “hepatic ectopic pregnancy”, and “primary
hepatic pregnancy” as keywords in PubMed, only 21
cases have been reported in the English literature of
which four were in Africa [3–6], and of the 21 reported
cases, one had medical treatment only [7].
Of these 21 cases, 61.9 % of cases presented with ab-
dominal pain and signs of hemoperitoneum on admis-
sion or during hospitalization. Other nonspecific signs
included localized abdominal tenderness (right upper
quadrant, right flank), spotting, and right upper quad-
rant masses with amenorrhea. These misleading signs
may point clinicians toward digestive and hepatobiliary
pathologies, thus delaying the diagnosis.
Abdominal ultrasound is a first-line medical imaging
modality in the diagnosis of ectopic pregnancy. However,
the accuracy is better with magnetic resonance imaging
(MRI), especially in describing the regional anatomy, the
precise location of the placenta, and key elements to de-
termine whether the placenta should be removed or not
[8]. Ultrasounds coupled with the βhCG titers were the
only available and affordable means of diagnosis used for
this patient. The site mostly described in the literature is
under the right lobe of the liver, as in our case [5–7].
The management of hepatic pregnancies is variable.
Surgery, either laparotomy or laparoscopy, is the most
described and used therapeutic option. The main chal-
lenge with this technique is the cataclysmic hemorrhage
that can occur during surgery. One patient died of mul-
tiorgan failure secondary to an uncontrollable bleeding
from the placenta site left in situ [9]. Common surgical
procedures used include hepatic artery ligation, lobec-
tomy, omental transplantation, and liver packing. Other
authors administered a direct injection of methotrexate
during a diagnostic laparotomy [10] or a combination of
preoperative arterial embolization, laparoscopic extrac-
tion of the fetus, and postoperative administration of
methotrexate for the placenta left in situ [11].
The hemodynamic stability of our patient and the fa-
vorable Fernandez score prompted us to choose the least
invasive approach, administration of methotrexate intra-
muscularly at a dose of 1 mg/kg. This dose was repeated
7 days later, as a precaution since a 15 % reduction in
βhCG titers had been obtained. This medical approach
is similar to what Shippey et al. did [7].
Conclusions
As clinicians, we should always rule out hepatic pregnancy
when faced with such a clinical presentation. Intramuscular
injection of methotrexate to the mother is the least invasive
treatment option reported in the treatment of hepatic preg-
nancies. It could be a safe therapeutic option in uncompli-
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